Retapamulin topical

Generic name: Retapamulin Topical
Brand names: Altabax
Dosage form: topical ointment (1%)
Drug class: Topical antibiotics

Usage of Retapamulin topical

Retapamulin topical (for the skin) is an antibiotic that is used to treat an infection called impetigo (im-pe-TYE-go). Impetigo usually affects the nose, lips, or other areas of the face, but it may also affect other areas of the body.

Retapamulin may be used for purposes not listed in this medication guide.

Retapamulin topical side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Wipe the ointment off your skin and call your doctor at once if you have:

severe burning, itching, redness, swelling, blistering, oozing, or other skin irritation where the medicine was applied; or

new or worsening signs of skin infection.

Common side effects of retapamulin topical may include:

mild itching or skin irritation; or

headache.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Retapamulin topical

Retapamulin topical is not approved for use by anyone younger than 9 months old.

Tell your doctor if you are pregnant

It may not be safe to breast-feed while using retapamulin topical. Ask your doctor about any risk.

Relate drugs

How to use Retapamulin topical

Usual Adult Dose for Impetigo:

Apply a thin layer to the affected area (up to 100 cm2 in total area) twice a day for 5 daysComments:-Consider alternative therapy if there is no improvement or worsening in the affected area after 2 to 3 days of treatment.Use: Topical treatment of impetigo due to methicillin-susceptible Staphylococcus aureus or Streptococcus pyogenes

Usual Pediatric Dose for Impetigo:

Apply a thin layer to the affected area (up to 2% total body surface area) twice a day for 5 daysComments:-For pediatric patients aged 9 months or older.-Concomitant use with strong CYP450 3A4 inhibitors is not recommended in patients younger than 24 months of age due to the higher systemic exposure of the drug in this patient population.-Consider alternative therapy if there is no improvement or worsening in the affected area after 2 to 3 days of treatment.Use: Topical treatment of impetigo due to methicillin-susceptible Staphylococcus aureus or Streptococcus pyogenes

Warnings

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

What other drugs will affect Retapamulin topical

Medicine used on the skin is not likely to be affected by other drugs you use. But many drugs can interact with each other.

Children younger than 2 years old can absorb larger amounts of retapamulin topical through the skin than adults. This could make it more likely that retapamulin topical could interact with other medications the child is using, especially antifungal or antiviral medicine, or other antibiotics.

Tell each of your healthcare providers about all medicines you use, including prescription and over-the-counter medicines, vitamins, and herbal products.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.